S&P 500   3,351.28 (+0.06%)
DOW   27,433.48 (+0.17%)
QQQ   271.47 (-1.15%)
AAPL   444.45 (-2.45%)
MSFT   212.48 (-1.79%)
FB   268.44 (+1.19%)
GOOGL   1,498.37 (-0.44%)
AMZN   3,167.46 (-1.78%)
NVDA   447.98 (-1.20%)
CGC   16.63 (-5.08%)
BABA   252.10 (-5.11%)
TSLA   1,452.71 (-2.48%)
MU   48.75 (+0.10%)
GE   6.40 (+1.11%)
AMD   84.85 (-2.15%)
T   30.02 (+0.60%)
F   6.86 (-1.01%)
ACB   10.27 (-0.39%)
GILD   69.35 (+0.78%)
NFLX   494.73 (-2.82%)
DIS   129.93 (-0.68%)
BAC   26.11 (+2.51%)
BA   170.02 (-1.27%)
S&P 500   3,351.28 (+0.06%)
DOW   27,433.48 (+0.17%)
QQQ   271.47 (-1.15%)
AAPL   444.45 (-2.45%)
MSFT   212.48 (-1.79%)
FB   268.44 (+1.19%)
GOOGL   1,498.37 (-0.44%)
AMZN   3,167.46 (-1.78%)
NVDA   447.98 (-1.20%)
CGC   16.63 (-5.08%)
BABA   252.10 (-5.11%)
TSLA   1,452.71 (-2.48%)
MU   48.75 (+0.10%)
GE   6.40 (+1.11%)
AMD   84.85 (-2.15%)
T   30.02 (+0.60%)
F   6.86 (-1.01%)
ACB   10.27 (-0.39%)
GILD   69.35 (+0.78%)
NFLX   494.73 (-2.82%)
DIS   129.93 (-0.68%)
BAC   26.11 (+2.51%)
BA   170.02 (-1.27%)
S&P 500   3,351.28 (+0.06%)
DOW   27,433.48 (+0.17%)
QQQ   271.47 (-1.15%)
AAPL   444.45 (-2.45%)
MSFT   212.48 (-1.79%)
FB   268.44 (+1.19%)
GOOGL   1,498.37 (-0.44%)
AMZN   3,167.46 (-1.78%)
NVDA   447.98 (-1.20%)
CGC   16.63 (-5.08%)
BABA   252.10 (-5.11%)
TSLA   1,452.71 (-2.48%)
MU   48.75 (+0.10%)
GE   6.40 (+1.11%)
AMD   84.85 (-2.15%)
T   30.02 (+0.60%)
F   6.86 (-1.01%)
ACB   10.27 (-0.39%)
GILD   69.35 (+0.78%)
NFLX   494.73 (-2.82%)
DIS   129.93 (-0.68%)
BAC   26.11 (+2.51%)
BA   170.02 (-1.27%)
S&P 500   3,351.28 (+0.06%)
DOW   27,433.48 (+0.17%)
QQQ   271.47 (-1.15%)
AAPL   444.45 (-2.45%)
MSFT   212.48 (-1.79%)
FB   268.44 (+1.19%)
GOOGL   1,498.37 (-0.44%)
AMZN   3,167.46 (-1.78%)
NVDA   447.98 (-1.20%)
CGC   16.63 (-5.08%)
BABA   252.10 (-5.11%)
TSLA   1,452.71 (-2.48%)
MU   48.75 (+0.10%)
GE   6.40 (+1.11%)
AMD   84.85 (-2.15%)
T   30.02 (+0.60%)
F   6.86 (-1.01%)
ACB   10.27 (-0.39%)
GILD   69.35 (+0.78%)
NFLX   494.73 (-2.82%)
DIS   129.93 (-0.68%)
BAC   26.11 (+2.51%)
BA   170.02 (-1.27%)
Log in

NYSE:DVADavita Stock Price, Forecast & News

$82.37
+0.08 (+0.10 %)
(As of 08/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$81.48
Now: $82.37
$83.71
50-Day Range
$75.56
MA: $82.62
$91.30
52-Week Range
$53.51
Now: $82.37
$92.16
Volume773,439 shs
Average Volume1.32 million shs
Market Capitalization$10.05 billion
P/E Ratio12.99
Dividend YieldN/A
Beta1.23
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services; vascular access services; clinical research programs; physician services; and comprehensive care services. As of December 31, 2018, it provided dialysis and administrative services in the United States through a network of 2,664 outpatient dialysis centers serving approximately 202,700 patients; and operated 241 outpatient dialysis centers located in 9 countries outside of the United States serving approximately 25,000 patients. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was founded in 1994 and is headquartered in Denver, Colorado.
Read More
Davita logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.1Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.26 out of 5 stars


Industry, Sector and Symbol

Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryHealth Care Services
SectorMedical
CUSIP23918K10
Phone720-631-2100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.39 billion
Cash Flow$11.21 per share
Book Value$19.13 per share

Profitability

Net Income$810.98 million

Miscellaneous

Employees65,000
Market Cap$10.05 billion
Next Earnings Date11/3/2020 (Estimated)
OptionableOptionable
$82.37
+0.08 (+0.10 %)
(As of 08/7/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive DVA News and Ratings via Email

Sign-up to receive the latest news and ratings for DVA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Davita (NYSE:DVA) Frequently Asked Questions

How has Davita's stock been impacted by COVID-19 (Coronavirus)?

Davita's stock was trading at $74.87 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, DVA shares have increased by 10.0% and is now trading at $82.37.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Davita?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Davita in the last year. There are currently 8 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Davita
.

When is Davita's next earnings date?

Davita is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Davita
.

How were Davita's earnings last quarter?

Davita Inc (NYSE:DVA) issued its quarterly earnings data on Thursday, July, 30th. The company reported $1.95 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.30 by $0.65. The firm had revenue of $2.88 billion for the quarter, compared to analysts' expectations of $2.91 billion. Davita had a return on equity of 40.78% and a net margin of 7.20%.
View Davita's earnings history
.

What guidance has Davita issued on next quarter's earnings?

Davita updated its FY20 earnings guidance on Thursday, July, 30th. The company provided EPS guidance of $6.25-$6.75 for the period, compared to the Thomson Reuters consensus estimate of $6.11. The company issued revenue guidance of $11.5-$11.7 billion, compared to the consensus revenue estimate of $11.70 billion.

What price target have analysts set for DVA?

10 Wall Street analysts have issued 12-month price objectives for Davita's shares. Their forecasts range from $57.00 to $100.00. On average, they expect Davita's share price to reach $71.17 in the next twelve months. This suggests that the stock has a possible downside of 13.6%.
View analysts' price targets for Davita
.

Has Davita been receiving favorable news coverage?

News articles about DVA stock have been trending very positive this week, according to InfoTrie. The research firm identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Davita earned a media sentiment score of 4.0 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future.
View the latest news about Davita
.

Are investors shorting Davita?

Davita saw a increase in short interest in July. As of July 31st, there was short interest totaling 6,040,000 shares, an increase of 5.6% from the July 15th total of 5,720,000 shares. Based on an average daily trading volume, of 1,090,000 shares, the short-interest ratio is presently 5.5 days. Currently, 5.0% of the company's shares are short sold.
View Davita's Current Options Chain
.

Who are some of Davita's key competitors?

What other stocks do shareholders of Davita own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Davita investors own include CA (CA), BlackRock (BLK), Chipotle Mexican Grill (CMG), Endologix (ELGX), Aegean Marine Petroleum Network (ANW), Micron Technology (MU), United Rentals (URI), AutoZone (AZO), Walt Disney (DIS) and Gilead Sciences (GILD).

Who are Davita's key executives?

Davita's management team includes the following people:
  • Mr. Kent J. Thiry, Chairman & CEO (Age 63)
  • Mr. Joel Ackerman, Chief Financial Officer (Age 54)
  • Mr. James K. Hilger, Chief Accounting Officer (Age 57)
  • Ms. Kathleen Alyce Waters, Chief Legal Officer (Age 51)
  • Mr. Javier J. Rodriguez, Chief Exec. Officer of DaVita Kidney Care (Age 48)

What is Davita's stock symbol?

Davita trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."

Who are Davita's major shareholders?

Davita's stock is owned by many different retail and institutional investors. Top institutional investors include Robeco Institutional Asset Management B.V. (1.38%), LSV Asset Management (0.82%), Thornburg Investment Management Inc. (0.44%), BNP PARIBAS ASSET MANAGEMENT Holding S.A. (0.38%), State of Michigan Retirement System (0.38%) and Wedge Capital Management L L P NC (0.36%). Company insiders that own Davita stock include Charles Berg, John M Nehra, Kent J Thiry, Pamela M Arway and Paul J Diaz.
View institutional ownership trends for Davita
.

Which institutional investors are selling Davita stock?

DVA stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, Sumitomo Mitsui Trust Holdings Inc., Hexavest Inc., Thornburg Investment Management Inc., Mackay Shields LLC, WINTON GROUP Ltd, New York State Common Retirement Fund, and Mn Services Vermogensbeheer B.V.. Company insiders that have sold Davita company stock in the last year include Charles Berg, John M Nehra, Kent J Thiry, Pamela M Arway, and Paul J Diaz.
View insider buying and selling activity for Davita
.

Which institutional investors are buying Davita stock?

DVA stock was acquired by a variety of institutional investors in the last quarter, including State of Michigan Retirement System, LSV Asset Management, Todd Asset Management LLC, Robeco Institutional Asset Management B.V., Victory Capital Management Inc., Venturi Wealth Management LLC, UBS Group AG, and Pacer Advisors Inc..
View insider buying and selling activity for Davita
.

How do I buy shares of Davita?

Shares of DVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Davita's stock price today?

One share of DVA stock can currently be purchased for approximately $82.37.

How big of a company is Davita?

Davita has a market capitalization of $10.05 billion and generates $11.39 billion in revenue each year. The company earns $810.98 million in net income (profit) each year or $5.40 on an earnings per share basis. Davita employs 65,000 workers across the globe.

What is Davita's official website?

The official website for Davita is www.davita.com.

How can I contact Davita?

Davita's mailing address is 2000 16TH STREET, DENVER CO, 80202. The company can be reached via phone at 720-631-2100 or via email at [email protected]

This page was last updated on 8/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.